The higher price of healthcare in America (US) and in other places can limit the flexibility of patients to manage and adhere to treatment method selections. As a result, by way of their respective associations/bodies, companies can champion policy proposals that advocate a cap on out-of-pocket spending on all prescription prescription drugs based